If an echocardiography report mentions elevated pulmonary pressure, increased PAPs or sPAP, or wording such as "probability of pulmonary hypertension", it means the echocardiogram has identified findings compatible with a possible increase in pressure in the pulmonary circulation. This does not automatically mean that pulmonary hypertension has been diagnosed.
Echocardiography estimates certain pressures using Doppler ultrasound and assesses how the right heart and pulmonary artery respond to pressure loading. The result must therefore be interpreted together with measurement quality, other echocardiographic parameters, symptoms, known medical conditions and any risk factors.
One point prevents much of the confusion: the PAPs estimated by echocardiography is not the same as mean pulmonary arterial pressure used to define pulmonary hypertension hemodynamically. The threshold of mean pressure greater than 20 mmHg refers to a measurement obtained by right heart catheterization and cannot be applied directly to a PAPs value in an echocardiography report.
The term pulmonary hypertension covers a wide range of different conditions. Echocardiography is crucial for raising or strengthening clinical suspicion and may point toward certain causes, but it does not establish which form is present on its own.
The main points to understand are:
The abbreviation PAPs, often given in English as sPAP or PASP, stands for systolic pulmonary arterial pressure. On echocardiography it is normally estimated, rather than measured directly. Doppler ultrasound records the peak velocity of regurgitant flow through the tricuspid valve, known as TRV or tricuspid regurgitation velocity, and uses it to calculate a pressure gradient. An estimate of right atrial pressure is then added to this value.
In the absence of significant obstruction of the right ventricular outflow tract or pulmonary valve, right ventricular systolic pressure, often abbreviated as RVSP, can be used as an approximation of systolic pulmonary arterial pressure.
This method is very useful, but inevitably has sources of error. Doppler velocity is squared in the formula used to calculate the gradient, so even a small measurement inaccuracy can produce a larger difference in calculated pressure. Added to this is uncertainty in the estimate of right atrial pressure, usually obtained by observing the diameter of the inferior vena cava and its respiratory variation.
For these reasons, ESC/ERS guidelines do not recommend determining the probability of pulmonary hypertension from the estimated PAPs alone. The main Doppler parameter is peak TRV, interpreted alongside other echocardiographic signs.
A peak TRV greater than 2.8 m/s may suggest pulmonary hypertension, but this threshold alone cannot establish whether the condition is present or absent. Echocardiography is used to assign a low, intermediate or high echocardiographic probability, combining TRV with other features of the right heart and pulmonary circulation.
Findings that can strengthen suspicion include right ventricular or right atrial enlargement, flattening of the interventricular septum, changes in the pulmonary artery and flow through the right ventricular outflow tract, a dilated inferior vena cava with reduced respiratory variation, and signs of impaired right ventricular function.
Consequently, questions such as "Is a PAPs of 35 normal?", "Does a PAPs of 40 mean pulmonary hypertension?" or "How severe is it at 50 mmHg?" cannot be answered reliably from the number alone. Its significance varies with age, the technical quality of the examination, associated findings, the presence of cardiac or lung disease, symptoms and the reason the echocardiogram was requested.
Clinical severity also cannot be inferred simply from PAPs. How the right ventricle adapts to pressure loading is fundamental, and two people with similar estimated pressures may have very different conditions.
Echocardiographic estimation may overestimate or underestimate pressures measured invasively. A weak or incomplete Doppler signal may fail to record the true peak tricuspid regurgitation velocity; conversely, artifacts or incorrectly interpreted tracings can produce excessively high values. Severe tricuspid regurgitation can also make the relationship between jet velocity and pressure less reliable.
Estimation of right atrial pressure adds a further source of variability. In addition, conditions with high cardiac output may increase flow velocity and require particularly careful interpretation.
Studies comparing echocardiography and catheterization show that, at the patient-group level, Doppler ultrasound is very useful for screening and estimating disease probability, but in an individual the difference between estimated and invasively measured pressure may be clinically important. Thus, the modern purpose of echocardiography is not just to produce a number, but to integrate multiple parameters in an overall assessment of the right heart and the probability of pulmonary hypertension.
The next step depends on how convincing the finding is and, above all, on the clinical context. A mildly elevated estimate in an asymptomatic person with an already evident cardiac cause may require a different approach from a high echocardiographic probability in someone with unexplained dyspnea, exertional syncope or risk factors for pulmonary vascular disease.
Echocardiography may already suggest that the increased pressure is related to left heart disease, such as ventricular dysfunction or valvular disease. In other cases, respiratory disease, hypoxia, consequences of thromboembolism or forms of pulmonary arterial hypertension must be investigated.
Possible investigations include an electrocardiogram, BNP or NT-proBNP, pulmonary function tests with carbon monoxide diffusing capacity, selected blood tests, chest CT and ventilation/perfusion scintigraphy. The latter has a specific role in the investigation of chronic thromboembolic pulmonary hypertension.
If a form is suspected in which precise knowledge of hemodynamics would change the diagnosis and treatment, the assessment may proceed to right heart catheterization. However, not everyone with elevated echocardiographic PAPs needs catheterization.
A suspicious echocardiographic finding becomes more important if accompanied by rapidly worsening shortness of breath, a marked reduction in exercise capacity, presyncope or syncope with mild exertion, or signs of right ventricular failure such as substantial edema, systemic congestion and hypotension. When pulmonary vascular disease or right heart failure is highly likely, international recommendations call for expedited assessment at a specialist center.
If, instead, the finding is incidental and the person is stable, the priority is to have the entire echocardiogram interpreted in its clinical context. Reading PAPs in isolation, without the other parameters and without understanding why it was estimated, may lead either to unnecessary alarm or to false reassurance.
New severe dyspnea, substantial chest pain, loss of consciousness, marked cyanosis or signs of instability must not be managed by waiting for a scheduled appointment for "high pulmonary pressure": these symptoms may also indicate pulmonary embolism, coronary syndromes, arrhythmias or other acute conditions and require urgent assessment.
Does a PAPs of 40 mmHg mean I have pulmonary hypertension?
Not necessarily. PAPs is an estimate and must be interpreted alongside TRV, other echocardiographic signs, symptoms and clinical context. A single value is not sufficient to establish a diagnosis.
Does the 20 mmHg threshold also apply to echocardiography?
No. The threshold greater than 20 mmHg refers to mean pulmonary arterial pressure measured by right heart catheterization. It does not correspond to the PAPs or sPAP reported on echocardiography.
Can an echocardiogram give an inaccurate pulmonary pressure estimate?
Yes. Errors or limitations in measuring tricuspid regurgitation and estimating right atrial pressure can lead to overestimation or underestimation. Multiparametric interpretation is therefore essential.
Does a low echocardiographic probability always exclude pulmonary hypertension?
No. It reduces the likelihood of a significant form, but further investigations may be needed if clinical suspicion is strong or a predisposing condition is present.
Does elevated pulmonary pressure always require catheterization?
No. Catheterization is indicated when the result may change classification, prognosis or treatment, especially if pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension is suspected. The decision is individualized.
Informational notice: the information contained on this page is provided solely for informational and educational purposes and does not replace the advice, diagnosis or treatment provided by a physician. If needed, always consult a qualified healthcare professional.
Artificial intelligence transparency: this page was created with the support of artificial intelligence tools, used to assist in the production and processing of its content.